Immunology & protein enthusiast
Since 2016, I have performed research in characterizing and engineering immunologically relevant proteins.​ My doctoral and postdoctoral work has largely focused on cytokine and cytokine-receptor engineering for cancer indications. I have recently transitioned to applying protein engineering in the immuno-cardiology and regenerative medicine fields.
Currently, I am a postdoctoral scholar in the Garcia Lab at Stanford University. I am funded as a Mechanisms and Innovations in Cardiovascular Disease T32 Postdoctoral Fellow through the Stanford Cardiovascular Institute.
Education
Massachussetts Institute of Technology
Chemistry & Biology, BS
2015 - 2019
My freshman spring organic chemistry class inspired me to declare my major as chemistry. Learning about synthesis and the methodical ways we can create new molecules was thrilling to me, as I was interested in developing new drugs for cancer treatments.
My first research experience involved biochemical characterization of innate immune proteins in the lab of Professor Elizabeth M. Nolan. This solidified my interests in biological chemistry and proteins. I then spent two years as an undergraduate researcher in the lab of Professor K. Dane Wittrup where I learned to design antibodies and test them via in vivo tumor models.
Stanford University
Immunology, PhD
2019 - 2024
​
Postdoc
2025 - present
I knew that I wanted to spend my doctoral program applying protein engineering to innovate cancer treatments. I joined the lab of Professor K. Christopher Garcia where I have honed my skills in protein design & production, murine tumor models & toxicology, and immunological assays. My scientific contributions have led to several publications & manuscripts and two patents.
​
I successfully defended my thesis, "Modulating JAK/STAT Activation Through Induced Proximity," in 2024. My doctoral work was supported by an NSF GFRP award and a Stanford Graduate Fellowship.​​
​
My transition from PhD student to postdoctoral fellow was funded by the Parker Institute for Cancer Immunotherapy as a RISE Scholar. I am currently funded by the Mechanisms and Innovations in Cardiovascular Disease T32 Training Grant through the Stanford University Cardiovascular Institute. My postdoctoral work is focused on applying protein engineering to the intersection of immunology and cardiovascular disease.